STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
130
13F, latest reported quarter
Conversions, 180 days
19
Codes C/M, not in net · no price filed
What the filings say about HIVE
Insiders, 180 days
-$3.6M net sold
4 sellers · 0% of sales under a 10b5-1 plan
HIVE Digital Technologies insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HIVE Digital Technologies Ltd. insiders sold a net $3.6M of stock across 10 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 71.6% of the 92,600 shares held after it.
2 other insiders sold within 30 days.
130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Daubaras Darcy sold about $212.2K of HIVE on Jul 15, 2026; 2 other insiders sold within 30 days and 130 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 57.2% of the 58,900 shares held after it.
2 other insiders sold within 30 days.
130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Daubaras Darcy sold about $107.5K of HIVE on Jul 15, 2026; 2 other insiders sold within 30 days and 130 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
3 other insiders sold within 30 days.
130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Perrill Dave sold about $820.8K of HIVE on Jun 19, 2026; 3 other insiders sold within 30 days and 130 funds added in the latest 13F quarter.
10 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HIVE planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
HIVE mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Schwab Crypto Thematic ETF
$15.6M position · as of 2026-06-30
5.8%
Grayscale Bitcoin Miners ETF
$835.2K position · as of 2026-06-30
5.1%
Valkyrie Bitcoin Miners ETF
$15.4M position · as of 2026-06-30
4.5%
First Trust SkyBridge Crypto Industry and Digital Economy ETF
$3.4M position · as of 2026-05-31
3.0%
Fidelity Crypto Industry and Digital Payments ETF
$3.3M position · as of 2026-06-30
1.3%
Global X Blockchain ETF
$4.2M position · as of 2026-05-31
1.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $3.6M sold by insiders over 180 days, 130 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$331.3M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM HIVE
FY Mar 2026
$297.8M
FY Mar 2025
$115.3M
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
$79.1M
Mar 2026
$71.8M
Dec 2025
$93.1M
Sep 2025
$87.3M
Jun 2025
$45.6M
Mar 2025
$31.2M
Dec 2024
$29.2M
Sep 2024
$22.6M
At each fiscal year end
Single quarter
Net margin, TTM
-98.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM HIVE
FY Mar 2026
-49.8%
FY Mar 2025
-2.6%
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
-180.6%
Mar 2026
-106.3%
Dec 2025
-98.1%
Sep 2025
-18.1%
Jun 2025
+76.8%
Mar 2025
-169.9%
Dec 2024
+233.2%
Sep 2024
+0.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$19.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HIVE
FY Mar 2026
$40.8M
FY Mar 2025
$16.6M
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
-$10.7M
Mar 2026
$121.5M
Dec 2025
-$15.5M
Sep 2025
-$75.4M
Jun 2025
$10.2M
Mar 2025
$102.2M
Dec 2024
-$46.4M
Sep 2024
-$32.5M
At each fiscal year end
Single quarter
Debt to equity
0.56x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity HIVE
FY Mar 2026
0.00x
FY Mar 2025
0.01x
FY Mar 2024
0.03x
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
0.56x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.01x
Mar 2025
0.01x
Dec 2024
0.02x
Sep 2024
0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.24x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt HIVE
FY Mar 2026
30.59x
FY Mar 2025
4.68x
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
0.24x
Mar 2026
30.59x
Dec 2025
39.08x
Sep 2025
7.98x
Jun 2025
9.38x
Mar 2025
4.68x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-66.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity HIVE
FY Mar 2026
-30.3%
FY Mar 2025
-0.8%
FY Mar 2024
+13.0%
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
-66.4%
Mar 2026
-30.3%
Dec 2025
-25.3%
Sep 2025
+7.7%
Jun 2025
+12.1%
Mar 2025
-0.8%
Dec 2024
+28.8%
Sep 2024
+17.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-42.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HIVE
FY Mar 2026
-25.4%
FY Mar 2025
-0.7%
FY Mar 2024
+10.5%
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
-42.0%
Mar 2026
-25.4%
Dec 2025
-22.7%
Sep 2025
+6.7%
Jun 2025
+8.0%
Mar 2025
-0.7%
Dec 2024
+26.0%
Sep 2024
+14.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HIVE
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HIVE
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing HIVE
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
20.15x
Jun 2025
6.67x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$549.6M
market value at close 2026-10-26 on 2026-08-14 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value HIVE
FY Mar 2026
$293.6M
FY Mar 2025
$220.3M
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
$1.0B
Mar 2026
$293.6M
Dec 2025
$406.4M
Sep 2025
$646.9M
Jun 2025
$278.1M
Mar 2025
$220.3M
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield HIVE
FY Mar 2026
+13.0%
FY Mar 2025
+6.9%
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
+2.0%
Mar 2026
+13.0%
Dec 2025
+5.0%
Sep 2025
-1.4%
Jun 2025
+11.2%
Mar 2025
+6.9%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing HIVE
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HIVE ranks highest on growth (91st percentile) and institutional and government (66th), and lowest on risk and compliance (7th), among Financial Services peers.
Profitability
23
Inputs
Return on equity-66.4% · 21 pct, sector of 205
Return on assets-42.0% · 25 pct, sector of 266
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
52
Inputs
Debt to equity0.56x · 43 pct, sector of 181
Cash flow to debt0.24x · 61 pct, sector of 141
Growth
91
Inputs
Revenue growth, YoY+158.3% · 91 pct, sector of 245
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
16
Inputs
Net Form 4 buying (codes P and S), 180d-$3.6M · 32 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
66
Inputs
Funds adding, latest quarter130 · 66 pct, sector of 278
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
7
Inputs
Short interest, % of float+19.9% · 7 pct, sector of 390
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HIVE filings, in plain words
Are HIVE Digital Technologies insiders buying or selling HIVE?
In the 180 days to 2026-10-28, HIVE Digital Technologies insiders were net sellers, a net $3.6M across purchases and sales reported on Form 4, by 4 sellers.
Read the full summary
In the 180 days to 2026-10-28, HIVE Digital Technologies insiders were net sellers of HIVE, a net $3.6M across purchases and sales reported on Form 4 by 4 sellers. None of the 10 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.